Author | Country | Year of data collection | Sample based | Participant selection | Sample size | Age | % men | ||||
Case | Control | Case | Control | Case | Control | Case | Control | ||||
Anesi et al66 | USA | 2012 | Hospital-based | Consecutive patients | Random | 151 | 151 | 58.67±17.96 | 46.33±28.44 | 28.48 | 12.58 |
Apisarnthanarak et al78 | Thailand | 2004 | Hospital-based | Random | Random | 46 | 46 | 58.25±16.51 | 56.5±14.47 | 28.26 | 28.26 |
Aswani et al39 | India | 2011 | Hospital-based | NI | NI | 181 | 124 | 60.2±13.76 | 53.47±18.56 | 45.86 | 41.94 |
Borer et al42 | Israel | 2007 | Hospital-based | Consecutive patients | Not clear | 42 | 464 | 60.7±55.30 | 62.8±55 | NI | NI |
Briongos-Figuero et al55 | Spain | 2010 | Hospital-based | NI | Random | 97 | 103 | 78±14 | 77±13 | 45.40 | 31.10 |
Chitnis et al71 | USA | 2010 | Hospital-based | Consecutive patients | Not clear | 34 | 34 | 68.67±34.80 | 69.67±42.56 | 38.00 | 65.00 |
Colodner et al41 | Israel | 2005 | Hospital-based | Consecutive patients | Consecutive patients | 150 | 150 | 63.75±14.20 | 56±14 | 24.70 | 10.70 |
Colodner et al43 | Israel | NI | Hospital-based | Consecutive patients | Consecutive patients | 128 | 183 | 61.5±22.90 | 46.4±24.90 | 35.90 | 13.70 |
Dan et al72 | USA | 2012 | Hospital-based | Consecutive patients | Consecutive patients | 143 | 681 | 67.7±14.23 | 65.3±18.60 | 59.00 | 44.00 |
Ashley et al73 | USA | 1997 | Hospital-based | Consecutive patients | Consecutive patients | 64 | 79 | 67.30 | 61.80 | 45.30 | 69.60 |
García-Tello et al57 | Spain | 2012 | Hospital-based | Consecutive patients | Consecutive patients | 416 | 1108 | 72.60±20.50 | 54.70±29.80 | 36.10 | 21.50 |
Hayakawa et al67 | USA | 2009 | Hospital-based | NI | NI | 532 | 532 | 66.00±16.50 | 62.40±18.10 | 45.30 | 48.70 |
Hershow et al68 | USA | 1990 | Hospital-based | NI | NI | 15 | 10 | 54.00 | 44.00 | 53.00 | 30.00 |
Hershow et al68 | USA | 1990 | Hospital-based | NI | NI | 56 | 14 | 50.00 | 57.00 | 48.21 | 35.71 |
Hsu et al69 | USA | 2001 | Hospital-based | NI | NI | 91 | 86 | 73.8±15.20 | 68±17.40 | 43.00 | 49.00 |
Isendahl et al58 | Sweden | 2009 | Hospital-based | Consecutive patients | Random | 945 | 9390 | 65.62±15.7 | 58.90 | ||
Jinnah et al23 | Bangladesh | NI | Hospital-based | Random selection | Random selection | 150 | 150 | NI | NI | NI | NI |
Khurram et al50 | Pakistan | 1998 | Hospital-based | Consecutive patients | Consecutive patients | 37 | 20 | 52.8±15.10 | 34.9±21.20 | 54.10 | 65.00 |
Kim et al46 | Korea | 2008 | Hospital-based | Consecutive patients | Consecutive patients | 82 | 122 | 66.3±10.50 | 67.3±15.70 | 59.80 | 68.90 |
Manzur et al56 | Spain | 1997 | Hospital-based | Consecutive patients | Consecutive patients | 50 | 98 | 69.06±13.90 | 58.33±18.24 | 45.00 | 65.30 |
Park et al45 | Korea | 2007–2013 | Hospital-based | Consecutive patients | Random | 75 | 225 | NI | NI | 12.00 | 6.20 |
Ren et al32 | China | 2015 | Hospital-based | Consecutive patients | Not clear | 98 | 49 | NI | NI | NI | NI |
Saade et al70 | USA | 2000–2013 | Hospital-based | NI | NI | 428 | 59 041 | 62.95±12.10 | 66.75±5.76 | 100 | 100 |
Saibal et al24 | Bangladesh | 2009 | Hospital-based | Convenient and purposive | Convenient and purposive | 47 | 43 | 56.3±12.20 | 35.7±10.50 | 68.10 | 72.10 |
Silva et al27 | Brazil | 2002 | Hospital-based | Consecutive patients | Consecutive patients | 56 | 51 | 65.80 | 61.50 | ||
Søraas et al49 | Norway | 2010 | Hospital-based | Consecutive patients | Random | 100 | 190 | 55.00±19.00 | 64.00±17.00 | 12.00 | 12.00 |
Vinken et al15 | The Netherlands | 2014 | Hospital-based | Consecutive patients | NI | 283 | 283 | 73.30±12.10 | 72.20±13.10 | 0.00 | 0.00 |
Wright et al74 | USA | 1996 | Hospital-based | Consecutive patients | Consecutive patients | 118 | 317 | NI | NI | 30.50 | 15.10 |
Wright et al75 | USA | 1996 | Hospital-based | Consecutive patients | Consecutive patients | 67 | 381 | NI | NI | 17.90 | 16.00 |
For an expanded version of this table (ie, containing more details about the study population in each original report and bye case and control groups) refer to online supplemental tables 4 and 7.
NI, no information available.